Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population

This study has been completed.
Sponsor:
Collaborators:
Prevemed-Medibo
Medical Laboratory CRI
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00365911
First received: August 17, 2006
Last updated: June 1, 2011
Last verified: June 2011
  Purpose

Blood sample is taken for measurement of serum creatinine, cystatin C, clone V haemoglobin, cholesterol, urine acid, glycemia and CRP.

The medical file is gathered. There will be searched for an association between renal function and cardiovascular risk factors and risk factors by exposition to toxic substantia during work.


Condition Intervention
Healthy
Procedure: Taking blood sample

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • A possible association between renal clearance and found cardiovascular risk factors and risk factors by exposition to toxic substantia during work. [ Time Frame: At time T0 ] [ Designated as safety issue: No ]

Estimated Enrollment: 2000
Study Start Date: March 2006
Study Completion Date: December 2009
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: Taking blood sample
    A blood sample will be taken.
  Eligibility

Ages Eligible for Study:   20 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 20-55 years
  • Male and female subjects
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00365911

Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Prevemed-Medibo
Medical Laboratory CRI
Investigators
Principal Investigator: Raymond Vanholder, MD, PhD University Hospital, Ghent
Principal Investigator: Wim Van Biesen, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided by University Hospital, Ghent

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Arjan Van Der Tol, University Hospital Ghent
ClinicalTrials.gov Identifier: NCT00365911     History of Changes
Other Study ID Numbers: 2006/038
Study First Received: August 17, 2006
Last Updated: June 1, 2011
Health Authority: Belgium: Institutional Review Board

Keywords provided by University Hospital, Ghent:
No specific condition

Additional relevant MeSH terms:
Renal Insufficiency
Kidney Diseases
Urologic Diseases

ClinicalTrials.gov processed this record on August 18, 2014